首页>European Journal of Haematology>The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma
The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma
作者单位：Queen Elizabeth Hosp, Women & Childrens Hosp, Flinders Med Ctr, Div Haematol,Royal Adelaide Hosp[1]Univ Adelaide, Sch Med Sci, Myeloma Res Lab, Adelaide, SA, Australia[2]
换一批
换一批
